Opportunity ID: 303756

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-HG-18-001
Funding Opportunity Title: Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.172 — Human Genome Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Apr 18, 2018
Last Updated Date:
Original Closing Date for Applications: Sep 10, 2020
Current Closing Date for Applications: Sep 10, 2020
Archive Date: Oct 16, 2020
Estimated Total Program Funding: $1,500,000
Award Ceiling: $700,000
Award Floor:

Eligibility

Eligible Applicants: Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Small businesses
For profit organizations other than small businesses
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal governments (Federally recognized)
County governments
City or township governments
Special district governments
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Public housing authorities/Indian housing authorities
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA) solicits R01 grant applications to develop novel technologies that will enable no less than one order of magnitude improvement in DNA sequencing, and practical methods for direct RNA sequencing. Advances in genomics and more broadly in biomedical research have been greatly facilitated by significant and sustained DNA sequencing throughput increases and cost decreases. The goal now is to improve the quality and efficiency of DNA sequencing and enable direct RNA sequencing (e.g., longer read lengths, faster turn-around time, greater accuracy, and higher-throughput etc.) at reasonable costs with the anticipation that significant advances in any of these and related areas would make significant contributions to the mission of NHGRI and the field of genomics, including to many of NHGRIs other technology development goals.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-18-001.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E Use for due dates on or before May 24, 2020 PKG00241018 May 27, 2018 May 24, 2020 View
FORMS-F Use for due dates on or after May 25, 2020 PKG00259108 May 27, 2018 Sep 10, 2020 View

Package 1

Mandatory forms

303756 RR_SF424_2_0-2.0.pdf

303756 PHS398_CoverPageSupplement_4_0-4.0.pdf

303756 RR_OtherProjectInfo_1_4-1.4.pdf

303756 PerformanceSite_2_0-2.0.pdf

303756 RR_KeyPersonExpanded_2_0-2.0.pdf

303756 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

303756 RR_Budget_1_4-1.4.pdf

303756 RR_SubawardBudget30_1_4-1.4.pdf

303756 PHS398_ModularBudget_1_2-1.2.pdf

303756 PHS_AssignmentRequestForm_2_0-2.0.pdf

Package 2

Mandatory forms

303756 RR_SF424_2_0-2.0.pdf

303756 PHS398_CoverPageSupplement_5_0-5.0.pdf

303756 RR_OtherProjectInfo_1_4-1.4.pdf

303756 PerformanceSite_2_0-2.0.pdf

303756 RR_KeyPersonExpanded_2_0-2.0.pdf

303756 PHS398_ResearchPlan_4_0-4.0.pdf

303756 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

303756 RR_Budget_1_4-1.4.pdf

303756 RR_SubawardBudget30_1_4-1.4.pdf

303756 PHS398_ModularBudget_1_2-1.2.pdf

303756 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-09T12:44:57-05:00

Share This Post, Choose Your Platform!

About the Author: